Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,051.03 0.17 (0.02%) as of 4:30 Fri 6/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 110.03(B)
Last Volume: 750,617 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 255,165 311,759 469,743
Total Sell Value $188,697,290 $247,812,013 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 43 67 128
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 2430
  Page 50 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sing George L Director   –       •      –    2015-05-27 4 OE $19.69 $98,450 D/D 5,000 117,772     -
   Ingram Robert Alexander Director   –       •      –    2015-05-27 4 S $513.39 $707,965 D/D (1,379) 1,500     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-05-26 4 S $507.34 $9,339,737 D/D (18,370) 0     -
   Ingram Robert Alexander Director   –       •      –    2015-05-22 4 D $516.48 $1,956,426 D/D (3,788) 2,879     -
   Ingram Robert Alexander Director   –       •      –    2015-05-22 4 OE $293.53 $1,956,965 D/D 6,667 6,667     -
   Goldstein Joseph L Director   –       •      –    2015-05-22 4 S $513.74 $2,057,100 D/D (4,000) 20,000     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2015-05-22 4 OE $30.63 $2,342,902 D/D 13,464 4,945     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2015-05-22 4 S $515.60 $6,702,800 D/D (13,000) 4,481     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-05-22 4 D $516.48 $11,197,286 D/D (21,680) 18,370     -
   Van Plew Daniel P SVP & General Mgr Industrial O   •       –      –    2015-05-22 4 OE $21.25 $1,097,288 D/D 40,050 25,760     -
   Goldstein Joseph L Director   –       •      –    2015-05-19 4 A $0.00 $0 D/D 20,000 24,000     -
   Brown Michael S Director   –       •      –    2015-05-15 4 AS $495.00 $2,475,000 D/D (5,000) 0     -
   Brown Michael S Director   –       •      –    2015-05-15 4 OE $57.11 $285,550 D/D 5,000 5,000     -
   Landry Robert E SVP Finance & CFO   •       –      –    2015-04-08 4 D $449.50 $3,551,500 D/D (7,901) 7,099     -
   Landry Robert E SVP Finance & CFO   •       –      –    2015-04-08 4 OE $272.70 $2,727,000 D/D 10,000 15,000     -
   Vagelos P Roy Chairman of the Board   •       •      –    2015-04-01 4 GD $0.00 $0 I/I 462 154,804     -
   Baker Charles A Director   –       •      –    2015-03-25 4 AS $452.45 $2,274,785 D/D (5,000) 9,000     -
   Baker Charles A Director   –       •      –    2015-03-25 4 OE $18.61 $93,050 D/D 5,000 14,000     -
   Larosa Joseph J SVP General Counsel and Secret   •       –      –    2015-03-25 4 OE $59.20 $183,342 D/D 3,097 15,067     -
   Aberman Michael S SVP Strategy Investor Relation   •       –      –    2015-03-24 4 AS $474.79 $2,319,738 D/D (4,843) 12,498     -
   Aberman Michael S SVP Strategy Investor Relation   •       –      –    2015-03-23 4 D $476.50 $2,457,311 D/D (5,157) 17,341     -
   Aberman Michael S SVP Strategy Investor Relation   •       –      –    2015-03-18 4 AS $462.84 $1,600,542 D/D (3,442) 22,498     -
   Aberman Michael S SVP Strategy Investor Relation   •       –      –    2015-03-17 4 D $457.91 $1,858,199 D/D (4,058) 25,940     -
   Aberman Michael S SVP Strategy Investor Relation   •       –      –    2015-03-17 4 OE $24.00 $273,552 D/D 11,398 29,998     -
   Terifay Robert J SVP Commercial   •       –      –    2015-03-17 4 AS $448.01 $4,957,907 D/D (10,993) 20,029     -
  2430 Records found
  Previous  50  51  52  53  54  55  56  57  58  59  Next   
  Page 50 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us